A preliminary report using Oxethazaine (cas 126-27-2)—a potential new dental local anaesthetic
-
Add time:09/25/2019 Source:sciencedirect.com
Oxethazaine is the most potent local anaesthetic in use. It is claimed to be 2000 times more potent than lignocaine and 500 times more potent than cocaine as assessed in rabbits eyes. Currently, oxethazaine is used in an antacid preparation for the topical relief of pain in conditions such as hiatus hernia, where the local pH is very low. Since oxethazaine is active in an acidic environment, it was decided to use oxethazaine, in a pilot study of 20 patients requiring minor oral surgery procedures, at a concentration of 0.1% at pH 3, to assess its value in achieving dental local anaesthesia. It was found that the local anaesthesia achieved was sufficient in all patients to allow the operative procedure to proceed. In two of the patients, who presented with acute periapical pathology, satisfactory local anaesthesia was achieved with 0.1% oxethazaine following a failure with lignocaine 2 % and 1:80 000 adrenaline. The duration of anaesthesia was found to be similar to the average achieved with lignocaine 2% and 1:80 000 adrenaline.
We also recommend Trading Suppliers and Manufacturers of Oxethazaine (cas 126-27-2). Pls Click Website Link as below: cas 126-27-2 suppliers
Prev:Regular PapersThe Metabolic and Hemodynamic Effects of Oxethazaine (cas 126-27-2) in the Perfused Rat Liver
Next:Research paperAlteration of hepatic microcirculation by Oxethazaine (cas 126-27-2) and some vasoconstrictors in the perfused rat liver) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Biphasic effects of Oxethazaine (cas 126-27-2), a topical anesthetic, on the intracellular Ca2+ concentration of PC12 cells09/30/2019
- Acute and chronic toxicity of Oxethazaine (cas 126-27-2): A highly potent local anesthetic☆09/29/2019
- Clinical trial of aludrox and Oxethazaine (cas 126-27-2) in radiotherapy09/28/2019
- Effect of Oxethazaine (cas 126-27-2) HCl on control of food and water intake in the rat10/01/2019
- Short CommunicationMechanisms Involved in the Contraction of Intrahepatic Portal Vein Branches by Clomipramine and Oxethazaine (cas 126-27-2) in Isolated Perfused Rat Livers09/27/2019
- Research paperAlteration of hepatic microcirculation by Oxethazaine (cas 126-27-2) and some vasoconstrictors in the perfused rat liver09/26/2019
- Regular PapersThe Metabolic and Hemodynamic Effects of Oxethazaine (cas 126-27-2) in the Perfused Rat Liver09/24/2019
- Case reportOxethazaine (cas 126-27-2) as the source of mephentermine and phentermine in athlete's urine09/10/2019
- The abuse potential of Oxethazaine (cas 126-27-2): Effects of Oxethazaine (cas 126-27-2) on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models09/09/2019


